文献速递小儿耳鼻咽喉头颈外科

儿童甲状舌管囊肿与鳃裂囊肿切除术中预防性静脉抗生素使用的NSQIP-P分析

Prophylactic Intravenous Antibiotic Use in Thyroglossal Duct and Branchial Cleft Cyst Excision: A NSQIP-P Analysis.
PubMed 文献 · Otolaryngol Head Neck Surg · 2026-03-03

本研究基于NSQIP-P数据库回顾性分析2021至2023年接受甲状舌管囊肿或鳃裂囊肿切除术的儿童患者,评估预防性静脉抗生素使用模式及其对手术部位感染、非计划再入院和再手术的影响。结果显示两种手术中预防性静脉抗生素使用率分别为83.5%和68.0%,多因素分析未发现其显著改善结局,提示需重新评估其必要性。

要点

  • 儿童甲状舌管囊肿和鳃裂囊肿切除术中预防性静脉抗生素使用率较高(83.5%和68.0%)。
  • 多因素分析显示预防性静脉抗生素未显著降低手术部位感染、再入院或再手术风险。
  • 抗生素使用受种族、术后住院、伤口分类等因素影响,需重新评估其必要性。

核心结论

  • 儿童甲状舌管囊肿和鳃裂囊肿切除术中预防性静脉抗生素使用未一致降低不良结局。

研究设计与样本

  • 回顾性队列研究,查询NSQIP-P数据库2021至2023年≤18岁接受甲状舌管囊肿或鳃裂囊肿切除术的患儿,共纳入2106例甲状舌管囊肿和2837例鳃裂囊肿患者。

主要发现

  • 甲状舌管囊肿和鳃裂囊肿患者中分别有83.5%和68.0%接受了预防性静脉抗生素。
  • 西班牙裔 ethnicity、术后住院和清洁-污染伤口分类与两组中预防性静脉抗生素使用增加相关。
  • 在鳃裂囊肿患者中,较低年龄和非耳鼻咽喉科医生治疗预测预防性静脉抗生素使用减少。
  • 多变量分析中,预防性静脉抗生素在两种队列中均未显著影响感染、再入院或再手术率。

关键数值与推荐

  • 甲状舌管囊肿预防性静脉抗生素使用率83.5%,鳃裂囊肿68.0%。

临床怎么用

  • 临床应重新评估儿童甲状舌管囊肿和鳃裂囊肿切除术中预防性静脉抗生素的必要性,避免不必要的使用。

局限性

  • 本研究为回顾性队列研究,可能存在未调整的混杂因素,且未报告其他具体局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify patterns in prophylactic intravenous antibiotics (PIAB) usage for thyroglossal duct and branchial cleft cyst excisions, and to evaluate whether PIAB improve patient outcomes. STUDY DESIGN: Retrospective cohort study. SETTING: American College of Surgeons National Surgical Quality Improvement Program-Pediatric (NSQIP-P) Surgical Antibiotic Prophylaxis Database. METHODS: The NSQIP-P database was queried for pediatric patients (≤18) from 2021 to 2023 who underwent thyroglossal duct or branchial cleft cyst excision. Multivariate regressions assessed associations between PIAB use and outcomes including surgical site infection, unplanned readmission, and reoperation while adjusting for clinicodemographic factors (age, sex, race/ethnicity, admission status, surgical specialty, ASA classification, and wound classification). RESULTS: Of 2106 TGDC and 2837 BCC patients, 83.5% and 68.0% received PIAB, respectively. Hispanic ethnicity, postoperative admission, and clean-contaminated wound classification were associated with increased PIAB use in both groups. In BCC patients, younger age and treatment by non-otolaryngologists predicted decreased PIAB use. While univariate analysis in TGDC cases showed lower infection rates with PIAB (OR, 0.52; 95% CI, 0.30-0.95; P = .025), this was not significant on multivariate analysis (0.59, 0.34-1.08, P = .074). PIAB did not significantly affect infection, readmission, or reoperation rates in either cohort on multivariate analysis. CONCLUSION: PIAB use in pediatric TGDC and BCC excisions varies with clinicodemographic factors but did not consistently reduce adverse outcomes. These findings underscore the need to reevaluate the necessity of PIAB and encourage further investigations to develop evidence-based guidelines for pediatric neck mass surgery.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Abrahamson CW, McClelland TQ, Fei-Zhang DJ, et al. Prophylactic Intravenous Antibiotic Use in Thyroglossal Duct and Branchial Cleft Cyst Excision: A NSQIP-P Analysis. Otolaryngol Head Neck Surg. 2026. PMID: 41774563. doi:10.1002/ohn.70186

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。